Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Skye Bioscience, Inc. - Common Stock (NQ:SKYE)

1.270 -0.040 (-3.05%)

Streaming Delayed Price Updated: 9:51 AM EST, Dec 1, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	21,708
Open	1.280
Bid (Size)	1.270 (100)
Ask (Size)	1.280 (200)
Prev. Close	1.310
Today's Range	1.250 - 1.300
52wk Range	1.140 - 5.750
Shares Outstanding	417,247,333
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE

November 30, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company ↗

November 29, 2025

Here's why a fast-rising pharmaceutical trimmed—and not abandoned—by a specialist fund signals ongoing conviction in the stock.

Via The Motley Fool

Performance

YTD	-55.4%	-55.4%
1 Month	-18.1%	-18.1%
3 Month	-62.4%	-62.4%
6 Month	-43.3%	-43.3%
1 Year	-70.3%	-70.3%

More News

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience

November 29, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Skye Bioscience and Perrigo and Encourages Investors to Contact the Firm

November 28, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm

November 28, 2025

From Schall Law

Via GlobeNewswire

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE

November 26, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SKYE

November 26, 2025

From The DJS Law Group

Via Business Wire

SKYE Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the Skye Bioscience, Inc. Class Action Lawsuit

November 25, 2025

From Robbins LLP

Via GlobeNewswire

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm

November 25, 2025

From Schall Law

Via GlobeNewswire

Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your Rights - SKYE

November 25, 2025

Via NewMediaWire

Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your Rights - SKYE

November 25, 2025

Via TheNewswire.com

Bragar Eagel & Squire, P.C. Reminds Stockholders Spirit, Molina, Skye, and Perrigo of the Upcoming Deadlines and Urges Investors to Contact the Firm

November 24, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Lost Money on Skye Bioscience, Inc. (SKYE)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

November 24, 2025

Via NewMediaWire

Lost Money on Skye Bioscience, Inc. (SKYE)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

November 24, 2025

Via TheNewswire.com

Skye Bioscience to Participate in Upcoming Investment Conferences

November 24, 2025

Via Newsfile

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm

November 21, 2025

From Schall Law

Via GlobeNewswire

SKYE INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience

November 20, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Skye Bioscience and Perrigo and Encourages Investors to Contact the Firm

November 18, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit With the Schall Law Firm

November 18, 2025

From The Schall Law Firm

Via Business Wire

SKYE Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against Skye Bioscience, Inc.

November 18, 2025

From Robbins LLP

Via GlobeNewswire

5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity? ↗

November 18, 2025

Via The Motley Fool

5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out ↗

November 18, 2025

Via The Motley Fool

Rosen Law Firm Urges Skye Bioscience, Inc. (NASDAQ: SKYE) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

November 18, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

Insights Ahead: Skye Bioscience's Quarterly Earnings ↗

November 07, 2025

Via Benzinga

Frequently Asked Questions

Is Skye Bioscience, Inc. - Common Stock publicly traded?

Yes, Skye Bioscience, Inc. - Common Stock is publicly traded.

What exchange does Skye Bioscience, Inc. - Common Stock trade on?

Skye Bioscience, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Skye Bioscience, Inc. - Common Stock?

The ticker symbol for Skye Bioscience, Inc. - Common Stock is SKYE on the Nasdaq Stock Market

What is the current price of Skye Bioscience, Inc. - Common Stock?

The current price of Skye Bioscience, Inc. - Common Stock is 1.270

When was Skye Bioscience, Inc. - Common Stock last traded?

The last trade of Skye Bioscience, Inc. - Common Stock was at 12/01/25 09:51 AM ET

What is the market capitalization of Skye Bioscience, Inc. - Common Stock?

The market capitalization of Skye Bioscience, Inc. - Common Stock is 529.90M

How many shares of Skye Bioscience, Inc. - Common Stock are outstanding?

Skye Bioscience, Inc. - Common Stock has 530M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.